Scientists face the ramifications of the country’s departure from the European Union, from delays in laboratory supplies to difficulties hiring international students and faculty.

The recent move of the European Medicines Agency from London to Amsterdam is a reflection of the city’s vibrant life sciences and health sector and supporting industries.

The fast-track Global Talent visa will have no cap on the number of researchers able to come to the UK.

Scientists speak up about landmark drug approvals, political and environmental activism, and the redefinition of death.

Higher ed professionals from EU and non-EU countries are departing for jobs elsewhere, perhaps reflecting uncertainty over funding availability.

Prime Minister Boris Johnson says the immigration program will help the nation remain a science superpower post-Brexit.

Public health care will take a hit however Britain leaves the European Union, but a no-deal exit will cause the most harm, a new analysis shows.

From the effects of political upheaval on research to claims of gene-edited babies, the year has been a tumultuous one for the scientific community.

Watch as Nobel laureate Venki Ramakrishnan, who wrote the December Reading Frames essay, discusses Brexit and the importance of sharing scientific insights with the public.

Nearly three dozen Nobel laureates and Fields Medal winners sign a letter to the UK Prime Minister and the President of the European Commission.

As Britain’s departure date from the European Union approaches, drugmakers are preparing for potential changes to regulatory procedures and border controls.

If the UK leaves the EU in March without a deal, transport of insulin and other essential drugs could be delayed.

The plan would also allow non-EU countries to pay to participate in EU research programs, albeit without wielding “decisional power.”

The budget is smaller than what some researchers hoped for, and too high for at least one EU member state.

Alzheimer’s researcher John Hardy calls the departure “an unmitigated disaster” for science and healthcare in Britain.

Gender discrimination, Brexit, and climate change are among the issues that have received considerable attention from the scientific community this year.

A coin toss decides the agency’s post-Brexit home once it departs from London.

The $88 million agreement is part of efforts by the UK government to increase transatlantic collaboration as the country prepares to leave the European Union.

Some researchers have already been negatively affected by the U.K.’s decision to leave the European Union, though opinions on the eventual outcome remain mixed.